LMO1 expression in neuroblastoma cells reprograms tumor-associated macrophages to promote metastasis
Abstract
Neuroblastoma (NB) accounts for 10% of pediatric cancer-related deaths, is often highly metastatic at diagnosis, and has a 5-year-survival rate of
Fields of Study & Subjects
Immune cells in cancer
Neuroblastoma Research and Treatments
Cancer
Stress
Anesthesia
and Immune Response
Publication details
- Journal / source
- iScience
- Volume
- 29
- Issue
- 3
- Pages
- 115144–115144
- Publication date
- 25 February 2026
- Language
- EN